Human Longevity
PrivateLast Round
Series B
Extension
Aug 20, 2024
Est. Valuation
$310M
Total Funding Raised
$369.8M
Company Overview
Human Longevity is a biotechnology company that offers a platform integrating genomic and phenotypic data to enhance the understanding of human health and proactively address age-related health issues such as cancer, diabetes, obesity, heart and liver diseases, and dementia through advanced DNA sequencing and machine learning.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics, Medical Imaging
Business Model
B2C
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Human Longevity Comps
Public and private peers based on sector, stage, and business model.
Human Longevity Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Aug 20, 2024 | ||||
| Series C | Dec 7, 2018 | ||||
| Series B | Apr 4, 2016 | ||||
| Series A | Mar 4, 2014 |
Key People
Founding team and executive leadership
Human Longevity Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Emerging Technology Partners | Series B Extension, Series C |
| OS Fund | Series B, Series A |
| TVM Capital Healthcare | Series B Extension |
| GE Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
Nobel Prize-winning scientist Geoffrey Hinton joins as Scientific Advisor.
- Mar 25, 2026
Partnered with Longevity Escape Velocity Foundation to study human aging.
Human Longevity Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Human Longevity's valuation, stock price, and market status.
